...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Array and Zenith

noretreat - Zenith is involved in 2 cancer combo trials at the moment, MCRPC and TNBC, both of them involving a different Pfizer product. ZEN3694 has been tested with some 30 existing cancer drugs. I know that does not equal the hundreds that Pfizer is involved in but is a lot more than just one. At the risk of repeating myself, whatever BP that buys Zenith or RVX will have a treasure trove of IP to test for years to come. Being a baby biotech Zenith has to focus on the single best opportunity as they do not have the resources to do larger tests on multiple targets at this time, the same as any other baby biotech.

tada

Share
New Message
Please login to post a reply